
Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.
Hilary Baldwin, MD, is the medical director of the Acne Treatment and Research Center in Brooklyn, New York.